Industrial - Machinery
Compare Stocks
5 / 10Stock Comparison
IEX vs XYL vs ROP vs PNR vs DHR
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Machinery
Industrial - Machinery
Industrial - Machinery
Medical - Diagnostics & Research
IEX vs XYL vs ROP vs PNR vs DHR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Industrial - Machinery | Medical - Diagnostics & Research |
| Market Cap | $15.97B | $27.49B | $36.28B | $12.76B | $124.33B |
| Revenue (TTM) | $3.53B | $9.09B | $8.12B | $4.20B | $24.78B |
| Net Income (TTM) | $508M | $973M | $1.71B | $671M | $3.69B |
| Gross Margin | 44.4% | 38.6% | 69.4% | 40.9% | 60.7% |
| Operating Margin | 20.8% | 13.6% | 28.1% | 20.6% | 21.0% |
| Forward P/E | 25.5x | 20.9x | 16.1x | 14.8x | 20.8x |
| Total Debt | $1.82B | $1.94B | $9.30B | $1.64B | $18.42B |
| Cash & Equiv. | $580M | $1.48B | $297M | $102M | $4.62B |
IEX vs XYL vs ROP vs PNR vs DHR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| IDEX Corporation (IEX) | 100 | 134.8 | +34.8% |
| Xylem Inc. (XYL) | 100 | 174.3 | +74.3% |
| Roper Technologies,… (ROP) | 100 | 89.5 | -10.5% |
| Pentair plc (PNR) | 100 | 201.8 | +101.8% |
| Danaher Corporation (DHR) | 100 | 118.9 | +18.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IEX vs XYL vs ROP vs PNR vs DHR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
IEX ranks third and is worth considering specifically for momentum.
- +20.9% vs ROP's -38.0%
XYL is the #2 pick in this set and the best alternative if income & stability and long-term compounding is your priority.
- Dividend streak 15 yrs, beta 0.92, yield 1.4%
- 204.7% 10Y total return vs DHR's 219.3%
- Lower volatility, beta 0.92, Low D/E 16.5%, current ratio 1.63x
- PEG 0.91 vs DHR's 34.35
ROP carries the broadest edge in this set and is the clearest fit for growth exposure.
- Rev growth 12.3%, EPS growth -1.0%, 3Y rev CAGR 13.7%
- 12.3% revenue growth vs PNR's 2.3%
- 21.1% margin vs XYL's 10.7%
- Beta 0.43 vs PNR's 1.22
PNR is the clearest fit if your priority is efficiency.
- 9.9% ROA vs DHR's 4.5%, ROIC 12.1% vs 5.9%
Among these 5 stocks, DHR doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 12.3% revenue growth vs PNR's 2.3% | |
| Value | PEG 0.91 vs 34.35 | |
| Quality / Margins | 21.1% margin vs XYL's 10.7% | |
| Stability / Safety | Beta 0.43 vs PNR's 1.22 | |
| Dividends | 1.4% yield, 15-year raise streak, vs IEX's 1.3% | |
| Momentum (1Y) | +20.9% vs ROP's -38.0% | |
| Efficiency (ROA) | 9.9% ROA vs DHR's 4.5%, ROIC 12.1% vs 5.9% |
IEX vs XYL vs ROP vs PNR vs DHR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
IEX vs XYL vs ROP vs PNR vs DHR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ROP leads in 2 of 6 categories
PNR leads 2 • IEX leads 0 • XYL leads 0 • DHR leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ROP leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DHR is the larger business by revenue, generating $24.8B annually — 7.0x IEX's $3.5B. ROP is the more profitable business, keeping 21.1% of every revenue dollar as net income compared to XYL's 10.7%. On growth, ROP holds the edge at +11.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.5B | $9.1B | $8.1B | $4.2B | $24.8B |
| EBITDAEarnings before interest/tax | $945M | $1.8B | $3.2B | $983M | $7.2B |
| Net IncomeAfter-tax profit | $508M | $973M | $1.7B | $671M | $3.7B |
| Free Cash FlowCash after capex | $611M | $966M | $2.6B | $716M | $5.3B |
| Gross MarginGross profit ÷ Revenue | +44.4% | +38.6% | +69.4% | +40.9% | +60.7% |
| Operating MarginEBIT ÷ Revenue | +20.8% | +13.6% | +28.1% | +20.6% | +21.0% |
| Net MarginNet income ÷ Revenue | +14.4% | +10.7% | +21.1% | +16.0% | +14.9% |
| FCF MarginFCF ÷ Revenue | +17.3% | +10.6% | +31.4% | +17.0% | +21.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +8.9% | +2.7% | +11.3% | +2.6% | +3.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +27.8% | +14.5% | +59.1% | +12.9% | +9.8% |
Valuation Metrics
ROP leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 19.9x trailing earnings, PNR trades at a 43% valuation discount to DHR's 34.9x P/E. Adjusting for growth (PEG ratio), XYL offers better value at 1.29x vs DHR's 34.35x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $16.0B | $27.5B | $36.3B | $12.8B | $124.3B |
| Enterprise ValueMkt cap + debt − cash | $17.2B | $27.9B | $45.3B | $14.3B | $138.1B |
| Trailing P/EPrice ÷ TTM EPS | 33.51x | 29.50x | 24.82x | 19.94x | 34.85x |
| Forward P/EPrice ÷ next-FY EPS est. | 25.52x | 20.91x | 16.08x | 14.75x | 20.82x |
| PEG RatioP/E ÷ EPS growth rate | 6.27x | 1.29x | 2.59x | 1.52x | 34.35x |
| EV / EBITDAEnterprise value multiple | 18.58x | 15.54x | 14.57x | 14.66x | 18.21x |
| Price / SalesMarket cap ÷ Revenue | 4.62x | 3.04x | 4.59x | 3.06x | 5.06x |
| Price / BookPrice ÷ Book value/share | 4.02x | 2.40x | 1.91x | 3.38x | 2.38x |
| Price / FCFMarket cap ÷ FCF | 25.89x | 30.21x | 14.55x | 17.11x | 23.64x |
Profitability & Efficiency
PNR leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
PNR delivers a 17.7% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $7 for DHR. XYL carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to ROP's 0.47x. On the Piotroski fundamental quality scale (0–9), PNR scores 8/9 vs ROP's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.6% | +8.5% | +8.8% | +17.7% | +7.1% |
| ROA (TTM)Return on assets | +7.3% | +5.6% | +5.0% | +9.9% | +4.5% |
| ROICReturn on invested capital | +10.4% | +7.6% | +6.1% | +12.1% | +5.9% |
| ROCEReturn on capital employed | +11.6% | +8.5% | +7.7% | +15.0% | +7.0% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 6 | 8 | 7 |
| Debt / EquityFinancial leverage | 0.45x | 0.17x | 0.47x | 0.42x | 0.35x |
| Net DebtTotal debt minus cash | $1.2B | $463M | $9.0B | $1.5B | $13.8B |
| Cash & Equiv.Liquid assets | $580M | $1.5B | $297M | $102M | $4.6B |
| Total DebtShort + long-term debt | $1.8B | $1.9B | $9.3B | $1.6B | $18.4B |
| Interest CoverageEBIT ÷ Interest expense | 11.33x | 49.32x | 6.50x | 11.94x | 18.13x |
Total Returns (Dividends Reinvested)
PNR leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PNR five years ago would be worth $12,298 today (with dividends reinvested), compared to $7,893 for DHR. Over the past 12 months, IEX leads with a +20.9% total return vs ROP's -38.0%. The 3-year compound annual growth rate (CAGR) favors PNR at 11.8% vs ROP's -7.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +20.4% | -15.3% | -18.5% | -24.6% | -23.6% |
| 1-Year ReturnPast 12 months | +20.9% | -3.2% | -38.0% | -12.8% | -8.3% |
| 3-Year ReturnCumulative with dividends | +5.9% | +11.9% | -21.0% | +39.8% | -15.5% |
| 5-Year ReturnCumulative with dividends | +0.7% | +2.6% | -17.5% | +23.0% | -21.1% |
| 10-Year ReturnCumulative with dividends | +189.3% | +204.7% | +115.0% | +126.9% | +219.3% |
| CAGR (3Y)Annualised 3-year return | +1.9% | +3.8% | -7.6% | +11.8% | -5.5% |
Risk & Volatility
Evenly matched — IEX and ROP each lead in 1 of 2 comparable metrics.
Risk & Volatility
ROP is the less volatile stock with a 0.43 beta — it tends to amplify market swings less than PNR's 1.22 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IEX currently trades 96.0% from its 52-week high vs ROP's 60.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.95x | 0.92x | 0.43x | 1.22x | 0.94x |
| 52-Week HighHighest price in past year | $223.84 | $154.27 | $584.03 | $113.95 | $242.80 |
| 52-Week LowLowest price in past year | $157.25 | $114.15 | $313.86 | $77.02 | $172.06 |
| % of 52W HighCurrent price vs 52-week peak | +96.0% | +75.0% | +60.3% | +69.3% | +72.3% |
| RSI (14)Momentum oscillator 0–100 | 67.6 | 45.4 | 43.6 | 35.3 | 33.0 |
| Avg Volume (50D)Average daily shares traded | 713K | 2.1M | 1.2M | 1.6M | 4.2M |
Analyst Outlook
Evenly matched — IEX and XYL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: IEX as "Hold", XYL as "Hold", ROP as "Buy", PNR as "Hold", DHR as "Buy". Consensus price targets imply 43.8% upside for PNR (target: $114) vs 12.7% for IEX (target: $242). For income investors, XYL offers the higher dividend yield at 1.39% vs DHR's 0.70%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $242.14 | $151.57 | $457.64 | $113.56 | $247.00 |
| # AnalystsCovering analysts | 29 | 40 | 23 | 41 | 42 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | +1.4% | +0.9% | +1.3% | +0.7% |
| Dividend StreakConsecutive years of raises | 23 | 15 | 12 | 6 | 1 |
| Dividend / ShareAnnual DPS | $2.82 | $1.60 | $3.29 | $0.99 | $1.23 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.6% | +0.1% | +1.4% | +1.8% | +2.5% |
ROP leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). PNR leads in 2 (Profitability & Efficiency, Total Returns). 2 tied.
IEX vs XYL vs ROP vs PNR vs DHR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IEX or XYL or ROP or PNR or DHR a better buy right now?
For growth investors, Roper Technologies, Inc.
(ROP) is the stronger pick with 12. 3% revenue growth year-over-year, versus 2. 3% for Pentair plc (PNR). Pentair plc (PNR) offers the better valuation at 19. 9x trailing P/E (14. 8x forward), making it the more compelling value choice. Analysts rate Roper Technologies, Inc. (ROP) a "Buy" — based on 23 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IEX or XYL or ROP or PNR or DHR?
On trailing P/E, Pentair plc (PNR) is the cheapest at 19.
9x versus Danaher Corporation at 34. 9x. On forward P/E, Pentair plc is actually cheaper at 14. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Xylem Inc. wins at 0. 91x versus Danaher Corporation's 34. 35x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — IEX or XYL or ROP or PNR or DHR?
Over the past 5 years, Pentair plc (PNR) delivered a total return of +23.
0%, compared to -21. 1% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: DHR returned +219. 3% versus ROP's +115. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IEX or XYL or ROP or PNR or DHR?
By beta (market sensitivity over 5 years), Roper Technologies, Inc.
(ROP) is the lower-risk stock at 0. 43β versus Pentair plc's 1. 22β — meaning PNR is approximately 186% more volatile than ROP relative to the S&P 500. On balance sheet safety, Xylem Inc. (XYL) carries a lower debt/equity ratio of 17% versus 47% for Roper Technologies, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IEX or XYL or ROP or PNR or DHR?
By revenue growth (latest reported year), Roper Technologies, Inc.
(ROP) is pulling ahead at 12. 3% versus 2. 3% for Pentair plc (PNR). On earnings-per-share growth, the picture is similar: Xylem Inc. grew EPS 7. 4% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, XYL leads at 17. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IEX or XYL or ROP or PNR or DHR?
Roper Technologies, Inc.
(ROP) is the more profitable company, earning 19. 4% net margin versus 10. 6% for Xylem Inc. — meaning it keeps 19. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ROP leads at 28. 3% versus 13. 5% for XYL. At the gross margin level — before operating expenses — ROP leads at 69. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IEX or XYL or ROP or PNR or DHR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Xylem Inc. (XYL) is the more undervalued stock at a PEG of 0. 91x versus Danaher Corporation's 34. 35x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Pentair plc (PNR) trades at 14. 8x forward P/E versus 25. 5x for IDEX Corporation — 10. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PNR: 43. 8% to $113. 56.
08Which pays a better dividend — IEX or XYL or ROP or PNR or DHR?
All stocks in this comparison pay dividends.
Xylem Inc. (XYL) offers the highest yield at 1. 4%, versus 0. 7% for Danaher Corporation (DHR).
09Is IEX or XYL or ROP or PNR or DHR better for a retirement portfolio?
For long-horizon retirement investors, Roper Technologies, Inc.
(ROP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 43), 0. 9% yield, +115. 0% 10Y return). Both have compounded well over 10 years (ROP: +115. 0%, PNR: +126. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IEX and XYL and ROP and PNR and DHR?
These companies operate in different sectors (IEX (Industrials) and XYL (Industrials) and ROP (Industrials) and PNR (Industrials) and DHR (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.